RAC 4.05% $1.54 race oncology ltd

I have said it before and I will say it again. We are at the...

  1. 163 Posts.
    lightbulb Created with Sketch. 30
    I have said it before and I will say it again. We are at the party very early.
    The conclusion of our AML trial in Israel is further proof that the greater market only wants one thing from Race.
    Until we get phase 1 or phase 2 readouts from our 'all comers' trial using RC220 or a partnership is announced we wont have a new ATH.
    You only have to Look at NEU, DXB or CU6 to see how this plays out.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.